Researchers at UT Southwestern Medical Center have discovered a protein called HELZ2 that plays a crucial role in regulating cholesterol levels in the bloodstream. This protein acts as a “master switch,” controlling how much of a key cholesterol-carrying particle, apoB, is produced by the liver. By shortening the lifespan of the genetic instructions that lead to apoB production, HELZ2 can lower the amount of harmful cholesterol that enters the bloodstream, potentially reducing the risk of heart disease.

This discovery is significant for anyone interested in maintaining heart health and preventing age-related conditions. Lower levels of apoB are associated with less plaque buildup in arteries, which can lead to heart attacks and strokes. The research shows that manipulating HELZ2 could lead to new treatments for heart disease and fatty liver disease, offering a fresh approach to managing cholesterol without relying solely on traditional medications like statins.

The evidence comes from a study that involved genetic screening in mice, revealing that those with increased HELZ2 activity had lower levels of harmful lipoproteins, including LDL cholesterol. However, this also led to higher fat accumulation in the liver, indicating a complex balance that needs to be managed. While the findings are promising, they are still in the early stages, focusing on animal models rather than large human trials. Therefore, while the potential for new cholesterol management strategies exists, more research is needed before any new treatments can be confirmed for human use.

For those looking to improve their cholesterol levels, it’s essential to maintain a balanced diet and engage in regular physical activity. These lifestyle choices can help support overall cardiovascular health while we await further developments in cholesterol regulation research.

Source: sciencedaily.com